Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome

Neurological Sciences

Volumn 32, Issue 6, 2011, Pages 1213-1217

  Gulisano, Mariangela ^a   Calì, Paola V ^a   Cavanna, Andrea E ^b,c   Eddy, Clare ^b   Rickards, Hugh ^b   Rizzo, Renata ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aripiprazole; Electrocardiogram; Pimozide; QTc interval; Tourette syndrome

Indexed keywords

ARIPIPRAZOLE; PIMOZIDE;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CHILD; CLINICAL ASSESSMENT; DIASTOLIC BLOOD PRESSURE; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GILLES DE LA TOURETTE SYNDROME; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; QT PROLONGATION; SCHOOL CHILD; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CHILD; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; LONGITUDINAL STUDIES; MALE; PIMOZIDE; PIPERAZINES; QUINOLONES; TIME FACTORS; TOURETTE SYNDROME;

EID: 84856233953     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0678-1     Document Type: Article

References (30)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association Text Revision (DSM-IV-TR), Washington
2. Robertson MM (2000) Tourette syndrome, associated conditions and the complexities of treatment. Brain 123:425-462 (Pubitemid 30099531)
3. Cavanna AE, Servo S, Monaco F, Robertson MM (2009) The behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci 21:13-23
4. Robertson MM, Cavanna AE (2008) Tourette syndrome: The facts, 2nd edn. Oxford University press, Oxford
5. Robertson MM, Stern JS (2009) Gilles de la Tourette syndrome: Symptomatic treatment based on evidence. Eur Child Adolesc Psychiatry 9(Suppl 1):160-175
6. Kimber TE (2010) An update on Tourette syndrome. Curr Neurol Neurosci Rep 10:286-291
7. Cavanna AE, Stecco A, Rickards H, Servo S, Terazzi E, Peterson B et al (2010) Corpus callosum abnormalities in Tourette syndrome: A MRI-DTI study of monozygotic twins. J Neurol Neurosurg Psychiatry 81:533-535
8. Pringsheim T, Marras C (2009) Pimozide for tics in Tourette's syndrome. Cochrane Database Syst Rev 2:CD006996
9. Sallee FR, Sethuraman G, Rock CM (1994) Effects of pimozide on cognition in children with Tourette syndrome: Interaction with comorbid attention deficit hyperactivity disorder. Acta Psychiatrica Scand 90:4-9 (Pubitemid 24212165)
10. Moldofsky H, Brown GM (1982) Tics and serum prolactin response to pimozide in Tourette syndrome. Adv Neurol 35: 387-390
11. Degrauw RS, Li JZ, Gilbert DL (2009) Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome. Pediatr Neurol 41:183-186
12. Bruun RD (1988) Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder. Am J Psychiatry 145:621-624
13. Drolet B, Rousseau G, Daleau P, Cardinal R, Simard C, Turgeon J (2001) Pimozide (Orap) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current in native cardiac myocytes. J Cardiovasc Pharmacol Ther 6:255-260 (Pubitemid 34296588)
14. Fulop G, Phillips RA, Shapiro AK, Gomes JA, Shapiro E, Nordlie JW (1987) ECG changes during haloperidol and pimozide treatment of Tourette's disorder. Am J Psychiatry 144:673-675 (Pubitemid 17067352)
15. Flockhart DA, Drici MD, Kerbusch T, Soukhova N, Richard E, Pearle PL et al (2000) Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. J Clin Psychopharmacol 20:317-324 (Pubitemid 30318360)
16. Greenaway M, Elbe D (2009) Focus on aripiprazole: A review of its use in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry 18:250-260
17. Pae CU (2009) A review of the safety and tolerability of aripiprazole. Expert Opin Drug Saf 8:373-386
18. Robertson MM, Eapen V (1996) The National Hospital Interview Schedule for the assessment of Gilles de la Tourette syndrome. Int J Methods Psychiatr Res 6:203-206
19. Robertson MM, Banerjee S, Kurlan R, Cohen DJ, Leckman J, McMahon W et al (1999) The Diagnostic Confidence Index: Development and clinical associations. Neurology 53:2108-2112
20. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ (1989) The Yale Global Tic Severity Rating Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566-573 (Pubitemid 19196295)
21. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK et al (1997) Children's Yale-Brown Obsessive Compulsive Scale: Reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844-852 (Pubitemid 27250450)
22. Conners K (1978) Conner's Parents and Teacher Rating scales. The Psychological Corporation, San Antonio
23. March JS (1997) Multidimensional Anxiety Scale for children (MASC). Multi-Health System Incorporation, Toronto
24. Kovacks M (1988) Children's depression inventory (CDI). Organizzazioni Speciali, Firenze
25. Rubini V, Padovani F (1986) Weschler Intelligence Scale for children-revised (WISC-R). Organizzazioni Speciali, Firenze
26. Bazett HC (1920) An analysis of the time-relations of electrocardiograms. Heart 7:353-370
27. Bat-Pitault F, Delorme R (2009) Aripiprazole and hypertension in adolescents. J Child Adolesc Psychopharmacol 19:601-602
28. Pitchot W, Ansseau M (2010) Aripiprazole, hypertension, and confusion. J Neuropsychiatry Clin Neurosci 22:123.E33
29. Borras L, Constant EL, Eytan A, Huguelet P (2005) Hypertension and aripiprazole. Am J Psychiatry 162:2392
30. Zareba W, Lin DA (2003) Antipsychotic drugs and QT interval prolongation. Psychiatr Q 74:291-306 (Pubitemid 38115323)